Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer

Vasohibin‐1 (VASH1) is a VEGF‐inducible endothelium‐derived angiogenesis inhibitor, and vasohibin‐2 (VASH2), its homolog, exhibits proangiogenic activity. VASH2 is expressed by various cancer cells and accelerates tumor angiogenesis and progression. VASH2 was recently shown to exhibit tubulin carbox...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Koyanagi, Takahiro, Saga, Yasushi, Takahashi, Yoshifumi, Tamura, Kohei, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Takei, Yuji, Urabe, Masashi, Mizukami, Hiroaki, Fujiwara, Hiroyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2021
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8026928/
https://ncbi.nlm.nih.gov/pubmed/33710778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3841
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi